ACRS — Aclaris Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapMomentum Trap

Annual balance sheet for Aclaris Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	54.1	191	218	119	114
Net Total Accounts Receivable
Net Total Receivables	0.772	0.623	0.484	0.298	0.318
Prepaid Expenses
Total Current Assets	57.5	205	232	129	126
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	5.78	4.77	3.78	5.48	3.85
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	70.8	251	255	197	220
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	14.9	22.9	21.9	31	31.6
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	33.1	53.9	57	40.2	64.8
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	37.6	197	198	157	156
Total Liabilities & Shareholders' Equity	70.8	251	255	197	220
Total Common Shares Outstanding